Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Moodys
Medtronic
Express Scripts
Dow

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Cnty Line Pharms Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for CNTY LINE PHARMS, and what generic and branded alternatives to CNTY LINE PHARMS drugs are available?

CNTY LINE PHARMS has fifteen approved drugs.



Summary for Cnty Line Pharms
US Patents:0
Tradenames:12
Ingredients:10
NDAs:15

Drugs and US Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET, EXTENDED RELEASE;ORAL 204772-001 Feb 29, 2016 AB RX No No   Start Trial   Start Trial
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-004 Aug 1, 1984 DISCN Yes No   Start Trial   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 DISCN No No   Start Trial   Start Trial
Cnty Line Pharms LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial
Cnty Line Pharms DYNACIN minocycline hydrochloride CAPSULE;ORAL 063067-001 Jul 31, 1990 AB RX No No   Start Trial   Start Trial
Cnty Line Pharms BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 207635-001 Jun 5, 2017 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 4,012,444   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 3,900,481   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 4,005,209   Start Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 4,005,209   Start Trial
Cnty Line Pharms LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 3,592,930   Start Trial
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 4,066,755   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Moodys
Merck
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.